Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026

Go back to Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026
(NASDAQ: DRMA) Delayed: 1.23 +0.06 (5.13%)
Previous Close $1.17    52 Week High
Open $1.20    52 Week Low
Day High $1.26    P/E N/A 
Day Low $1.20    EPS
Volume 49,259